variant,gene_symbol,summary,clinical_importance,evidence,impact,frequency,category,inheritance,zygosity,PMIDs,dbSNP_ID,penetrance_score,build_37_chromosome,build_37_position,build_37_variant_allele,getev_report_url
F11-F301L,F11,"Causes factor XI deficiency, causing increased bleeding and impaired clotting. Recorded in ClinVar by OMIM (http://www.ncbi.nlm.nih.gov/clinvar/RCV000012667/), this effect seems to be well-established by literature and is found in patients with Ashkenazi ancestry. Asakai et al 1991 (PMID: 2052060) called this variant ""Type III"" and report it accounted for 47% of disease-causing alleles in 46 patients studied.",High,Well-established,Pathogenic,,Other,Recessive,Heterozygous,,,5,,,,http://evidence.pgp-hms.org/genomes?display_genome_id=f1e29bc9f8e009de553e7e32fd279039d71a1379&access_token=f2d395f0498a4423a01d56cf30fea433
ABCA4-G1961E,ABCA4,"This rare variant causes Stargardt Disease in a recessive manner. It was hypothesized to increase susceptibility to age-related macular degeneration, but subsequent studies have contradicted this hypothesis.",High,Likely,Pathogenic,0.0027,Hearing and vision,Recessive,Heterozygous,9295268;9973280;10958763;11346402;19217903,rs1800553,5,chr1,94473807,T,http://evidence.pgp-hms.org/genomes?display_genome_id=f1e29bc9f8e009de553e7e32fd279039d71a1379&access_token=f2d395f0498a4423a01d56cf30fea433
RP1-T373I,RP1,"Reported to cause recessive retinitis pigmentosa in some Pakistani families. Because it is unclear whether these families have some common ancestry, and because there may be an uncharacterized linked variant, this pathogenic effect of this variant is considered uncertain.",High,Uncertain,Pathogenic,0.012,Hearing and vision,Recessive,Heterozygous,11095597;15863674,rs77775126,5,chr8,55537560,T,http://evidence.pgp-hms.org/genomes?display_genome_id=f1e29bc9f8e009de553e7e32fd279039d71a1379&access_token=f2d395f0498a4423a01d56cf30fea433
SLC7A9-A182T,SLC7A9,"Reported to cause cystinuria when homozygous, may also have symptoms when heterozygous. Although authors reporting the variant as confidently causal and it has some supporting functional evidence, we are unable to establish that the variant has statistical significance for this association.",Moderate,Uncertain,Pathogenic,0.0033,Genital and urinary;Metabolism,Recessive,Heterozygous,10471498;11157794;15635077,rs79389353,5,chr19,33353427,T,http://evidence.pgp-hms.org/genomes?display_genome_id=f1e29bc9f8e009de553e7e32fd279039d71a1379&access_token=f2d395f0498a4423a01d56cf30fea433
CYP1B1-R368H,CYP1B1,"This variant has been associated with early onset open-angle glaucoma and juvenile open-angle glaucoma, acting as a modifier to a variant in another gene or compound heterozygously with other more severe variants in the same gene.",Moderate,Uncertain,Pathogenic,0.0015,Hearing and vision,Recessive,Heterozygous,11774072;14507861;17591938;17718864,rs79204362,3,chr2,38298394,T,http://evidence.pgp-hms.org/genomes?display_genome_id=f1e29bc9f8e009de553e7e32fd279039d71a1379&access_token=f2d395f0498a4423a01d56cf30fea433
MTRR-I49M,MTRR,"This common variant (HapMap allele frequency of 31.3%) in a protein involved in folate (B9) and cobalamin (B12) metabolism and is often reported as ""MTRR I22M"" (an alternative transcript position). Mothers homozygous for this variant are associated with having around a increased chance of a child with Down syndrome (risk of 0.4%, average risk in population is 0.25%). Notably, age plays a far larger role in the rate of Down syndrome (risk is 4.5% for a mother 45-years-of-age), and it is unknown how this variant may combine with the effect of age. There are conflicting reports associating this variant with incidence of neural tube defects, possibly when combined with MTHFR A222V.",Low,Likely,Pathogenic,0.45,Anatomical and congenital;Metabolism;Nervous system,Recessive,Homozygous,10444342;10930360;11807890;12375236;15060097;15979034;17024475,rs1801394,1,chr5,7870973,G,http://evidence.pgp-hms.org/genomes?display_genome_id=f1e29bc9f8e009de553e7e32fd279039d71a1379&access_token=f2d395f0498a4423a01d56cf30fea433
COL4A1-Q1334H,COL4A1,"This common variant has been associated with arterial stiffness and, in Japanese, a small increased risk of myocardial infarction (MI, a.k.a. heart attack). This last observation supported a dominant effect for this variant and, assuming a lifetime risk of 15% for MI, we estimate carriers have an additional risk of 0.5-3%.",Low,Likely,Pathogenic,0.32,Heart and circulatory,Dominant,Heterozygous,10334796;18077766;20031579,rs3742207,2,chr13,110818598,G,http://evidence.pgp-hms.org/genomes?display_genome_id=f1e29bc9f8e009de553e7e32fd279039d71a1379&access_token=f2d395f0498a4423a01d56cf30fea433
NOD2-R702W,NOD2,"NOD2 encodes a protein involved in bacterial recognition. This variant is associated with Crohn's disease in European populations, but not in Korean or Japanese groups.",Low,Likely,Pathogenic,0.033,"Mouth, liver, and digestive",Complex/Other,Heterozygous,11875755;12202985;12529700,rs2066844,1,chr16,50745926,T,http://evidence.pgp-hms.org/genomes?display_genome_id=f1e29bc9f8e009de553e7e32fd279039d71a1379&access_token=f2d395f0498a4423a01d56cf30fea433
TGIF1-P83Shift,TGIF1,"Severe variants in this gene are associated with holoprosencephaly disorders when combined with loss-of-function variants in SHH. Haploinsufficiency was identified in some families with this condition. It is unclear how likely this variant is to occur in combination with an SHH variant, or what phenotypic effect the variant would have on its own.",Low,Uncertain,Pathogenic,0.14,Nervous system,Complex/Other,Heterozygous,10556296,rs11571510,1,,,,http://evidence.pgp-hms.org/genomes?display_genome_id=f1e29bc9f8e009de553e7e32fd279039d71a1379&access_token=f2d395f0498a4423a01d56cf30fea433
ELAC2-S217L,ELAC2,"Reported to be associated with increased susceptibility to prostate cancer, but later studies weaken the hypothesis. Xu et al.'s meta-analysis concludes that there is a small but significant increased risk (OR = 1.13). Assuming a lifetime risk of 16% for prostate cancer we calculate this leads to an increased risk of ~1.5% (17.5% total).",Low,Uncertain,Pathogenic,0.27,Cancer;Genital and urinary,Complex/Other,Heterozygous,12384782;15368467;18767027;20231859,rs4792311,2,chr17,12915009,A,http://evidence.pgp-hms.org/genomes?display_genome_id=f1e29bc9f8e009de553e7e32fd279039d71a1379&access_token=f2d395f0498a4423a01d56cf30fea433
TP53-P72R,TP53,"This is a common variant was first reported as a polymorphism. It has since had mixed associations with cancer: Storey et al. conclude a 7x *increased* risk of HPV cancer for homozygotes vs hets, but Jones et al. find a 1.98x *decreased* risk for colorectal cancer. This variant may have significant impact on particular cancers, but it is unclear what effect it has on the overall burden of cancer.",Low,Uncertain,Pathogenic,0.63,Cancer,Unknown,Homozygous,1975675;9607760;15355915;19837266;20615891;22184967,rs1042522,0,chr17,7579472,C,http://evidence.pgp-hms.org/genomes?display_genome_id=f1e29bc9f8e009de553e7e32fd279039d71a1379&access_token=f2d395f0498a4423a01d56cf30fea433
SP110-L425S,SP110,"This variant is associated with a slightly increased risk of tuberculosis. It is unclear whether it is itself causal, or in linkage disequilibrium with some other causal variant that has a stronger effect.",Low,Uncertain,Pathogenic,0.86,Immune system,Unknown,Homozygous,16803959,rs3948464,1,chr2,231050715,G,http://evidence.pgp-hms.org/genomes?display_genome_id=f1e29bc9f8e009de553e7e32fd279039d71a1379&access_token=f2d395f0498a4423a01d56cf30fea433
H6PD-R453Q,H6PD,"This common variant may have a small pathogenic effect by contributing to cortisone reductase deficiency (a rare abnormality) when homozygous and combined with a serious pathogenic variant. The same authors have tested and ruled out a contribution to polycystic ovary syndrome (similar phenotype, more common disease).",Low,Uncertain,Pathogenic,0.31,Genital and urinary;Metabolism,Recessive,Heterozygous,12858176;15827106;16817821,rs6688832,1,chr1,9323910,A,http://evidence.pgp-hms.org/genomes?display_genome_id=f1e29bc9f8e009de553e7e32fd279039d71a1379&access_token=f2d395f0498a4423a01d56cf30fea433
WFS1-R611H,WFS1,"This nonsynonymous SNP is associated with Wolfram Syndrome (known as DIDMOAD), which is characterized by early-onset non-autoimmune diabetes mellitus, diabetes insipidus, optic atrophy, and deafness) and to adult Type Two Diabetes Mellitus.  The WFS1 gene maps to chromosome 4p16.3.  The variant has been shown to be statistically associated with type II diabetes in six UK studies and one study of Ashkenazi Jews (Sandhu, M., et al., Minton et al.).",Low,Uncertain,Not Reviewed,0.4,Hearing and vision;Immune system;Metabolism,Recessive,Heterozygous,17603484;17719176;23257691,rs734312,1,chr4,6303354,A,http://evidence.pgp-hms.org/genomes?display_genome_id=f1e29bc9f8e009de553e7e32fd279039d71a1379&access_token=f2d395f0498a4423a01d56cf30fea433
rs1544410,,"rs1544410 is a Vitamin D Receptor (VDR) single nucleotide polymorphism. It is unlikely that it has functional significance because it is located in an intron (Liu et. al.), but it is in strong linkage disequilibrium with rs731236 (Dvornyk et al), which is located in an exon. ",Low,Uncertain,Pharmacogenetic,0.35,Other,Unknown,Heterozygous,,rs1544410,0,,,,http://evidence.pgp-hms.org/genomes?display_genome_id=f1e29bc9f8e009de553e7e32fd279039d71a1379&access_token=f2d395f0498a4423a01d56cf30fea433
CFH-V62I,CFH,"Associated with a decreased risk for age related macular degeneration (ARMD). Homozygotes for this have a 4-5% decreased attributable risk (3-4% vs. average 8% risk), heterozygotes have slightly lower than average risk (7%). Non-carriers have an increased risk (12-13%). ARMD impairs sharp vision as age progresses. While there is no cure, treatment can slow progression of the disease and environmental factors (smoking and obesity) contribute to higher risk.",Low,Likely,Protective,0.39,Hearing and vision;Metabolism,Complex/Other,Heterozygous,15870199,rs800292,2,chr1,196642233,A,http://evidence.pgp-hms.org/genomes?display_genome_id=f1e29bc9f8e009de553e7e32fd279039d71a1379&access_token=f2d395f0498a4423a01d56cf30fea433
KCNJ11-K23E,KCNJ11,"This variant is associated with decreased risk of type 2 diabetes. It is unclear whether this variant has additive effects, or acts in a dominant or recessive manner. Assuming diabetes has a lifetime risk of 36%, we estimate a decreased risk of around 1-2% per copy of this variant.",Low,Likely,Protective,0.74,Metabolism,Unknown,Heterozygous,17463246;17463248;20054294,rs5219,2,chr11,17409572,C,http://evidence.pgp-hms.org/genomes?display_genome_id=f1e29bc9f8e009de553e7e32fd279039d71a1379&access_token=f2d395f0498a4423a01d56cf30fea433
IRS2-G1057D,IRS2,"a.k.a Gly1057Asp, insulin receptor substrate-2 IRS2. The rs1805097(G) allele is associated with the Gly, and the (A) allele with Asp. 
A longevity study concluded that rs1805097(A;A) individuals were about twice as likely to live over 85 y/o (odds ratio 2.03, CI:1.39-2.99, p = .0003). ",Low,Uncertain,Protective,0.23,Other,Unknown,Homozygous,19887537,rs1805097,,chr13,110435231,T,http://evidence.pgp-hms.org/genomes?display_genome_id=f1e29bc9f8e009de553e7e32fd279039d71a1379&access_token=f2d395f0498a4423a01d56cf30fea433
BRCA2-T1915M,BRCA2,Serrano-Fernández et al. found this variant to be associated with a modest (OR = 1.61) but significant (P = 0.0007) reduction in breast cancer risk.  ,Low,Uncertain,Protective,0.021,Cancer,Unknown,Heterozygous,19030985,rs4987117,,chr13,32914236,T,http://evidence.pgp-hms.org/genomes?display_genome_id=f1e29bc9f8e009de553e7e32fd279039d71a1379&access_token=f2d395f0498a4423a01d56cf30fea433
CACNA1S-L458H,CACNA1S,Common polymorphism,Low,Likely,Benign,0.27,Other,Unknown,Heterozygous,,rs12742169,,chr1,201052310,T,http://evidence.pgp-hms.org/genomes?display_genome_id=f1e29bc9f8e009de553e7e32fd279039d71a1379&access_token=f2d395f0498a4423a01d56cf30fea433
COL6A3-D2831H,COL6A3,"Probably benign, reported by Pan et al. as a presumed-nonpathogenic variant in the gene.",Low,Likely,Benign,0.068,Other,Unknown,Heterozygous,9536084;15563506,rs36104025,,chr2,238247734,G,http://evidence.pgp-hms.org/genomes?display_genome_id=f1e29bc9f8e009de553e7e32fd279039d71a1379&access_token=f2d395f0498a4423a01d56cf30fea433
OCA2-R305W,OCA2,"This variant is associated with eye color, as is OCA2 Arg419Gln. Individuals with this variant are more likely to have brown/black eyes (as opposed to blue/gray or green/hazel). Other variants in this gene are associated with oculocutaneous albinism (albinism which involves skin and eyes).",Low,Likely,Benign,0.082,Hearing and vision;Skin,Unknown,Heterozygous,"12163334;
15889046",rs1800401,,chr15,28260053,A,http://evidence.pgp-hms.org/genomes?display_genome_id=f1e29bc9f8e009de553e7e32fd279039d71a1379&access_token=f2d395f0498a4423a01d56cf30fea433
NEFL-S472Shift,NEFL,"Although a frameshift in this gene would be predicted to cause Charcot-Marie Neuropathy, this particular position appears to reflect a single base insertion error/mutation in the reference genome (in other words, normal individuals are always homozygous for a deletion at this position relative to reference). See chr8:24,811,060-24,811,080 annotations on UCSC.",Low,Likely,Benign,,Nervous system,Unknown,Homozygous,,rs11340767,,,,,http://evidence.pgp-hms.org/genomes?display_genome_id=f1e29bc9f8e009de553e7e32fd279039d71a1379&access_token=f2d395f0498a4423a01d56cf30fea433
KEL-T193M,KEL,This variant is also known as Kell or K1 or K (capitalized) in the Kell antigen system. K1-negative mothers (carrying no copies of this variant) carrying K1-positive fetuses (heterozygous or homozygous) are at risk for hemolytic disease of the newborn. About 9% of caucasians carry one or two copies of K1.,Low,Uncertain,Benign,0.032,Blood,Dominant,Heterozygous,7849312,rs8176058,,chr7,142655008,A,http://evidence.pgp-hms.org/genomes?display_genome_id=f1e29bc9f8e009de553e7e32fd279039d71a1379&access_token=f2d395f0498a4423a01d56cf30fea433
MLH1-I219V,MLH1,"Computational evidence, functional assays, and case/control studies suggest this variant is probably benign.",Low,Uncertain,Benign,0.24,Other,Dominant,Homozygous,11781295;12810663;17074586;17510385;17870204;19863800;20301390;22631669,rs1799977,0,chr3,37053568,G,http://evidence.pgp-hms.org/genomes?display_genome_id=f1e29bc9f8e009de553e7e32fd279039d71a1379&access_token=f2d395f0498a4423a01d56cf30fea433
TYR-S192Y,TYR,This variant is reported to affect skin pigmentation. It is associated with lighter skin in South Asians (OR 4-5) and with a lack of freckles in Europeans (OR 1.3).,Low,Uncertain,Benign,0.27,Skin,Unknown,Homozygous,17952075;17999355,rs1042602,,chr11,88911696,A,http://evidence.pgp-hms.org/genomes?display_genome_id=f1e29bc9f8e009de553e7e32fd279039d71a1379&access_token=f2d395f0498a4423a01d56cf30fea433
GALT-N314D,GALT,"This variant has an allele frequency of ~8% and is ancestral to ""Duarte"" / ""Duarte 2"" and ""Duarte 1""/""Los Angeles"" galactosemia variants. This variant is evolutionarily ancestral, and in vitro studies fail to support an impact of this variant on enzyme activity. Carney et al. instead implicate a 4 base deletion on the 5' of the GALT gene as being causal and linked to this variant. Galactosemia is typically screened and detected in infants and causes early, severe but nonspecific symptoms (digestive problems, lethargy, failure to thrive).",Low,Uncertain,Benign,0.072,"Mouth, liver, and digestive",Unknown,Heterozygous,10408771;11261429;19224951,rs2070074,,chr9,34649442,G,http://evidence.pgp-hms.org/genomes?display_genome_id=f1e29bc9f8e009de553e7e32fd279039d71a1379&access_token=f2d395f0498a4423a01d56cf30fea433
NKX2-5-E21Q,NKX2,"Probably nonpathogenic. Reported in a single case of tetralogy of fallot (a congenital heart defect), although an unaffected mother and grandmother were also carriers. A later study also found the variant in an affected family, but the variant did not segregate with disease (other affected family members were *not* carriers) -- they conclude that it is probably a nonpathogenic polymorphism.",Low,Uncertain,Benign,0.00047,Heart and circulatory,Unknown,Heterozygous,11714651;12798584,rs104893904,,chr5,172662026,G,http://evidence.pgp-hms.org/genomes?display_genome_id=f1e29bc9f8e009de553e7e32fd279039d71a1379&access_token=f2d395f0498a4423a01d56cf30fea433
PTCH1-P1315L,PTCH1,"Common polymorphism, presumed benign.",Low,Uncertain,Benign,0.3,Other,Unknown,Heterozygous,15712338,rs357564,,chr9,98209594,A,http://evidence.pgp-hms.org/genomes?display_genome_id=f1e29bc9f8e009de553e7e32fd279039d71a1379&access_token=f2d395f0498a4423a01d56cf30fea433
NTRK1-G613V,NTRK1,"Also called G607V, this variant has been reported as a nonpathogenic polymorphism.",Low,Uncertain,Benign,0.043,Other,Unknown,Heterozygous,10330344;10443680;11159935,rs6339,,chr1,156848946,T,http://evidence.pgp-hms.org/genomes?display_genome_id=f1e29bc9f8e009de553e7e32fd279039d71a1379&access_token=f2d395f0498a4423a01d56cf30fea433
PCSK9-G670E,PCSK9,This variant is likely benign. ,Low,Uncertain,Benign,0.89,Other,Unknown,Homozygous,19351729,rs505151,,chr1,55529187,A,http://evidence.pgp-hms.org/genomes?display_genome_id=f1e29bc9f8e009de553e7e32fd279039d71a1379&access_token=f2d395f0498a4423a01d56cf30fea433
NTRK1-H604Y,NTRK1,"Various databases and papers treat this variant as a non-pathogenic polymorphism, although it is fairly uncommon and is computational methods predict it to be damaging.",Low,Uncertain,Benign,0.043,Other,Unknown,Heterozygous,10443680;16412461;21228398,rs6336,,chr1,156848918,T,http://evidence.pgp-hms.org/genomes?display_genome_id=f1e29bc9f8e009de553e7e32fd279039d71a1379&access_token=f2d395f0498a4423a01d56cf30fea433
F5-M413T,F5,Presumed benign. This variant is not particularly rare and has not been reported to cause disease.,Low,Uncertain,Benign,0.058,Other,Unknown,Heterozygous,17284699,rs6033,,chr1,169521853,G,http://evidence.pgp-hms.org/genomes?display_genome_id=f1e29bc9f8e009de553e7e32fd279039d71a1379&access_token=f2d395f0498a4423a01d56cf30fea433
F5-D2222G,F5,"Other mutations in this gene are associated with Factor 5 deficiency. There is no literature implicating this variant, however, and it is fairly common in the population (3.8% in HapMap), and so it is currently labeled as benign.",Low,Uncertain,Benign,0.045,Blood,Unknown,Heterozygous,,rs6027,,chr1,169483561,C,http://evidence.pgp-hms.org/genomes?display_genome_id=f1e29bc9f8e009de553e7e32fd279039d71a1379&access_token=f2d395f0498a4423a01d56cf30fea433
PKP2-L366P,PKP2,This variant is a benign polymorphism.  ,Low,Uncertain,Benign,0.22,Other,Unknown,Heterozygous,19955750,rs1046116,,chr12,33021934,G,http://evidence.pgp-hms.org/genomes?display_genome_id=f1e29bc9f8e009de553e7e32fd279039d71a1379&access_token=f2d395f0498a4423a01d56cf30fea433
APOB-Y1422C,APOB,This position is almost certainly an error in the HG18 reference sequence. ,Low,Uncertain,Benign,1.0,Other,Unknown,Homozygous,,rs568413,,chr2,21235475,C,http://evidence.pgp-hms.org/genomes?display_genome_id=f1e29bc9f8e009de553e7e32fd279039d71a1379&access_token=f2d395f0498a4423a01d56cf30fea433
TAS2R38-A49P,TAS2R38,"This variant is strongly associated with causing the ""taster"" phenotype of phenylthiocarbamine (PTC) in a dominant manner.",Low,Uncertain,Benign,0.43,Other,Unknown,Homozygous,12595690;15883422;20675712,rs713598,,chr7,141673345,G,http://evidence.pgp-hms.org/genomes?display_genome_id=f1e29bc9f8e009de553e7e32fd279039d71a1379&access_token=f2d395f0498a4423a01d56cf30fea433
TAS2R38-I296V,TAS2R38,"This variant is associated with ""taster"" status of PTC, along with 49P and 262A. Due to linkage disequilibrium, the independent effects of positions 296 and 262 is unclear. The presence of 49P confers taster status in a dominant fashion, but in the absence of 49P, the presence of 262A/296V is still positively associated with tasting PTC.",Low,Uncertain,Benign,0.46,Other,Unknown,Homozygous,12595690;20675712,rs10246939,,chr7,141672604,C,http://evidence.pgp-hms.org/genomes?display_genome_id=f1e29bc9f8e009de553e7e32fd279039d71a1379&access_token=f2d395f0498a4423a01d56cf30fea433
SLC45A2-L374F,SLC45A2,"Pigmentation allele for non-black hair, and consequently, possible increased susceptibility to malignant melanoma.",Low,Uncertain,Benign,0.69,Cancer,Unknown,Homozygous,15714523;17044855;18563784;18806926,rs16891982,,chr5,33951693,G,http://evidence.pgp-hms.org/genomes?display_genome_id=f1e29bc9f8e009de553e7e32fd279039d71a1379&access_token=f2d395f0498a4423a01d56cf30fea433
RP1-N985Y,RP1,"Probably benign. One report linked this variant to high triglycerides, but a later paper found a nearby SNP with similar association and suggests that both findings are caused by linkage to an undiscovered causal variant.",Low,Uncertain,Benign,0.35,Metabolism,Unknown,Heterozygous,12764676;19364639,rs2293869,,chr8,55539395,T,http://evidence.pgp-hms.org/genomes?display_genome_id=f1e29bc9f8e009de553e7e32fd279039d71a1379&access_token=f2d395f0498a4423a01d56cf30fea433
TCIRG1-R56W,TCIRG1,"Probably benign. One publication implicates the variant in causing osteopetrosis, but this is contradicted by the relatively high allele frequency for the variant in Caucasians (5%, 1 in 400 homozygous) while that disease is extremely rare (1 in 250,000).",Low,Uncertain,Benign,0.044,"Muscular, skeletal, and connective tissue",Unknown,Heterozygous,12161516;19448635,rs36027301,,chr11,67809268,T,http://evidence.pgp-hms.org/genomes?display_genome_id=f1e29bc9f8e009de553e7e32fd279039d71a1379&access_token=f2d395f0498a4423a01d56cf30fea433
